Switch to: References

Add citations

You must login to add citations.
  1. If you build it, they will come: unintended future uses of organised health data collections.Kieran C. O’Doherty, Emily Christofides, Jeffery Yen, Heidi Beate Bentzen, Wylie Burke, Nina Hallowell, Barbara A. Koenig & Donald J. Willison - 2016 - BMC Medical Ethics 17 (1):54.
    Health research increasingly relies on organized collections of health data and biological samples. There are many types of sample and data collections that are used for health research, though these are collected for many purposes, not all of which are health-related. These collections exist under different jurisdictional and regulatory arrangements and include: 1) Population biobanks, cohort studies, and genome databases 2) Clinical and public health data 3) Direct-to-consumer genetic testing 4) Social media 5) Fitness trackers, health apps, and biometric data (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • Forensic uses of research biobanks: should donors be informed?Vilius Dranseika, Jan Piasecki & Marcin Waligora - 2016 - Medicine, Health Care and Philosophy 19 (1):141-146.
    Occasional reports in the literature suggest that biological samples collected and stored for scientific research are sometimes accessed and used for a variety of forensic purposes. However, donors are almost never informed about this possibility. In this paper we argue that the possibility of forensic access may constitute a relevant consideration at least to some potential research subjects in deciding whether to participate in research. We make the suggestion that if some type of forensic access to research collections is likely (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Accessing medical biobanks to solve crimes: ethical considerations.Nina F. de Groot, Britta C. van Beers, Lieven Decock & Gerben Meynen - 2021 - Journal of Medical Ethics 47 (7):502-509.
    Millions of human biological samples are stored worldwide for medical research or treatment purposes. These biospecimens are of enormous potential value to law enforcement as DNA profiles can be obtained from these samples. However, forensic use of such biospecimens raises a number of ethical questions. This article aims to explore ethical issues of using human bodily material in medical biobanks for crime investigation and prosecution purposes. Concerns about confidentiality, trust, autonomy and justice will be discussed. We explore how to balance (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Forensic DNA databases in European countries: is size linked to performance?Susana Silva, Helena Machado & Filipe Santos - 2013 - Life Sciences, Society and Policy 9 (1):1-13.
    The political and financial investments in the implementation of forensic DNA databases and the ethical issues related to their use and expansion justify inquiries into their performance and general utility. The main function of a forensic DNA database is to produce matches between individuals and crime scene stains, which requires a constant input of individual profiles and crime scene stains. This is conditioned, among other factors, by the legislation, namely the criteria for inclusion of profiles and the periods of time (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Retaining the Genetic Profile of Innocent People: A Difficult Balance Between Respecting the Individual's Privacy and Public Security.Luciana Caenazzo & Pamela Tozzo - 2013 - Synesis: A Journal of Science, Technology, Ethics, and Policy 4 (1).
    Download  
     
    Export citation  
     
    Bookmark  
  • Big Tobacco and the human genome: driving the scientific bandwagon?Helen M. Wallace - 2009 - Genomics, Society and Policy 5 (1):1-54.
    The tobacco industry first began to promote the idea that a minority of smokers are 'genetically predisposed' to lung cancer in the 1950s. We used tobacco industry documents available as a result of litigation to investigate the role of the tobacco industry in funding the 'scientific bandwagon' described by Fujimura, in which genetics has come to dominate the cancer research agenda. From 1990-1995 inclusive, 52% of the project funding allocated by British American Tobacco's Scientific Research Group went to genetic research, (...)
    Download  
     
    Export citation  
     
    Bookmark